Login

Skyfii Ltd CEO Wayne Arthur tells Proactive about securing several new contract wins in the global airport sector. 00:10:00

Share On Facebook Share On Twitter

Antony Karp is Former Interim CEO at Skyfii Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Jim Russo on Peloton, USMCA, the Fed, and U.S.-China Trade Tensions | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Centrica plc, owner of British Gas, reports a tripling of profits to £3.3 billion amid the ongoing energy crisis.
00:10:00
Protect your future with geneType risk assessment|Simon Morriss,CEO,Genetic Technologies Ltd
00:10:00
Toni Townes-Whitley, CEO of Science Applications International Corp. (SAIC), discusses the company's AI investments and fourth-quarter performance.
00:10:00
Star Royalties: Innovating the Royalty Space with Carbon Negative Gold Royalties
00:10:00
Insights from Namibia Critical Metals: Advancing Critical Mineral Projects in a Stable Mining Jurisdiction
00:10:00
Charles Murray on America's Civic Culture and Family Changes|Charles Murray
00:10:00
Union Square Ventures is a venture capital firm focused on earlystage startup financing|Nick Grossman,General Partner,Union Square Ventures
00:10:00
Charting Your Financial Course: Insights from DeeDee Baze & Pam Dunwald | DeeDee Baze - CEO of Alphemita Financial Services
00:10:00
Focused VC that accelerates startup founders with access|Amish Jani,Founder and Partner,FirstMark
00:10:00
Kelly Partners: Transforming Accounting with a Modern Approach and Significant Growth Potential
00:10:00
Eddie invests in most industries outside of Biotech and Hardware|Eddie Lee,Principal, White Star Capital

© 2026 Nehu